Connect with us

Technology

NUS scientists develop realistic ‘micro-gut’ model to study the relationship between gut microbes and human diseases

Published

on

The 3D scalable ‘gut-on-a-chip’ model enables real-time visualisation of the interactions of gut microbes and the human intestine

SINGAPORE, Feb. 10, 2025 /PRNewswire/ — In a breakthrough for the advanced study of gut health, scientists from the National University of Singapore (NUS) have developed a 3D microscopic version of the human intestines condensed into a small chip about half the size of a five-cent coin. This new cell culturing platform, known as the Gut-Microbiome on a chip (GMoC), provides a realistic in vitro microgut model that allows researchers to examine the interactions of gut microbes and their collective impact on gut health. The chip offers a scalable, reproducible, and efficient method to dissect the roles of gut microbes and their community, which is of key interest for the preventive healthcare and pharmaceuticals industry.

“The GMoC system represents a significant advancement in our ability to investigate the effect of the gut microbial community on gut health and diseases,” said Professor Lim Chwee Teck, Director of the NUS Institute for Health Innovation and Technology (iHealthtech). Prof Lim is also from the Department of Biomedical Engineering at the College of Design and Engineering, NUS. “By establishing a physiologically-relevant gut model capable of culturing communities of gut microbes, we can gain deeper insights into the role and complex mechanisms of these micro-organisms in maintaining gut health and preventing disease.”

Understanding the complex interplay of gut microbes and health

Our intestines contain trillions of bacteria, fungi, and viruses which play a crucial role in our overall well-being. These communities of microorganisms – also known collectively as the gut flora or gastrointestinal microbiome – can either help or harm us.

However, the exact mechanisms by which these gut microbes prevent or cause gastrointestinal illnesses remain unclear. While researchers have identified individual differences in the gut microbiomes of healthy people and those with diseases, the complexity of the interactions amongst the trillions of microorganisms residing in our intestines makes it difficult to isolate the exact modes of action by which these microbes protect us or induce disease.

The innovative 3D ‘microgut’ platform developed by NUS researchers provides a more realistic presentation of the gut microbial community compared to existing models. It simulates biological conditions (like food movement and oxygen levels) as in the human gut, mimics key structural and physiological features of the gut lining, allows for diverse communities of microbes to be cultivated, and is designed for easy and real-time investigation.

Mimicking the human gut

The GMoC system provides a realistic in vitro (outside the body) model of the human gut, featuring a 3D version of the gut epithelium that mimics key architectural and functional aspects of the intestinal tract, such as the intestinal villi (tiny finger-like projections for absorption of nutrients), co-inhabitation of microbes and intestinal cells, and the dynamic conditions simulating movement of food.

Replicating the structure of the intestinal villi is important because the specific location of different microbial species within a 3D substrate influences how they organise and function, and it also has a distinctive impact on the gut’s response to various stimuli.

In addition to structural features, the team’s ‘microgut’ platform also demonstrated key attributes of a functioning and physiologically-relevant intestinal epithelium. The ‘microgut’ can also produce mucin, which serves as a line of defence against microbial invasion and contributes to the establishment of the gut-bacteria interface.

The GMoC system is therefore a more complete in vitro model because it replicates, architecturally, the cells lining the human intestine, and offers a more physiologically-relevant model compared to existing static in vitro systems.

Real-time visualisation of inter-microbial interactions

Poised to be a versatile research tool, the innovative GMoC system enables scientists to study the inter-microbial interactions and gut-microbial community interactions in greater resolution and in real-time.

By studying how different bacterial species compete for limited resources such as nutrients and physical space for growth in the gut, and examining how this competition helps prevent harmful bacteria from overgrowing and disrupting the balanced gut microbiota in the gut, scientists can facilitate the development of targeted microbiome-based interventions and strategies for modulating gut microbiota.

The unique design of GMoC ensures scalability while enabling multiple tests to be performed on a single chip.

Future plans

The research team is focused on further developing the device, aiming to enhance its complexity to better replicate the human intestines. This includes incorporating complex mechanical cues, enhancing cellular complexity, and creating oxygen gradients within the GMoC system.

On the biological front, the team also aims to use the device to further investigate the assembly, interactions, and behaviour of diverse microbial communities under various stimuli including nutrients and antibiotics. This will contribute to our overall understanding of how these interactions impact gut health. In terms of commercialisation, the team is looking to bring the device to market by reducing the manufacturing costs and standardising the production process.

The GMoC chip offers a crucial advancement to the field by providing a realistic, in vitro platform for the investigation of the multifaceted roles of gut microorganisms in a highly scalable way. This will help scientists to better understand the mechanisms of microbe-induced disease pathogenesis, identify novel therapeutic targets, and develop treatments capable of modulating gut microbiome to improve health and clinical outcomes.

Read more at: https://news.nus.edu.sg/nus-scientists-develop-realistic-micro-gut-model/

View original content to download multimedia:https://www.prnewswire.com/news-releases/nus-scientists-develop-realistic-micro-gut-model-to-study-the-relationship-between-gut-microbes-and-human-diseases-302372091.html

SOURCE National University of Singapore

Continue Reading

Technology

MiniTool ShadowMaker 5.0 Introduces Cloud Sync for Google Drive and OneDrive

Published

on

By

VANCOUVER, BC, Oct. 22, 2026 /PRNewswire/ — MiniTool® Software Limited has announced the release of MiniTool ShadowMaker 5.0, the latest version of its Windows backup and file sync software. The update introduces a new Cloud Sync feature for Google Drive and OneDrive, along with enhancements to the registration and purchase experience, interface refinements, and compatibility fixes.

New Features and Improvements in MiniTool ShadowMaker 5.0

1. Cloud Sync to Google Drive and OneDrive

MiniTool ShadowMaker 5.0 introduces Cloud Sync, allowing users to synchronize files and folders from a Windows computer to Google Drive or OneDrive. Users can choose the files and folders they want to sync and select their preferred cloud storage service as the destination.

The new feature supports one-way synchronization from a local Windows PC to cloud storage, providing an additional way to save copies of important files outside of your computer. Together with MiniTool ShadowMaker’s existing local file sync function, Cloud Sync expands the available destinations for file sync.

2. Streamlined License & Plan Management

The latest update introduces an enhanced register interface that remains easily accessible even after activation. Registered users can now effortlessly review their current plan, explore upgrade options, or update their license key anytime for a smoother user experience.

These refinements are intended to improve usability when users manage their software registration and licensing.

3. Interface Refinements and Compatibility Fixes

MiniTool ShadowMaker 5.0 includes interface improvements and fixes for certain display issues. One notable fix addresses a blurry display issue that could occur on some systems equipped with AMD GPUs.

These changes focus on resolving specific issues and improving the user experience on affected systems.

4. Additional Improvements

Beyond Cloud Sync and the changes outlined above, MiniTool ShadowMaker 5.0 includes additional interface and functionality refinements. Together, these updates further improve the software’s usability while expanding its file synchronization options.

With support for Google Drive and OneDrive, MiniTool ShadowMaker 5.0 provides Windows users with another approach to manage file copies across local and cloud storage. Users who want to synchronize files to cloud storage can download the Free Edition and explore the new capabilities.

About MiniTool ShadowMaker

MiniTool ShadowMaker is a Windows backup and file sync solution designed to help users protect their operating systems and important data. It supports backing up Windows systems, disks, partitions, files, and folders to local drives, external hard drives, shared folders, and other supported locations. Users can select specific items to back up according to their needs.

For users who need to migrate data to another drive, MiniTool ShadowMaker offers a disk cloning feature. The software also supports restoring backed-up data and creating bootable media for system recovery.

By combining backup, file synchronization, disk cloning, and restore capabilities, MiniTool ShadowMaker offers Windows users a set of tools for data protection and system recovery.

About MiniTool® Software Limited

MiniTool Software Limited is a professional software company that develops computer applications. It provides software for partition management, data recovery, data backup and sync, video editing, multimedia conversion, and screen recording for home and business users. The company is committed to developing innovative, reliable, and easy-to-use software that simplifies everyday digital tasks.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minitool-shadowmaker-5-0-introduces-cloud-sync-for-google-drive-and-onedrive-302916663.html

SOURCE MiniTool® Software Limited

Continue Reading

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

on

By

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Continue Reading

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

on

By

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.

Continue Reading

Trending